CN Stock MarketDetailed Quotes

600223 Lushang Freda Pharmaceutical

Watchlist
  • 6.46
  • -0.02-0.31%
Market Closed Jul 19 15:00 CST
6.57BMarket Cap28.21P/E (TTM)

Lushang Freda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lushang Freda Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 30, 2024

Revenue(YoY)

890.64M

-29.99%
EPS(YoY)

0.06

-53.85%
Analyst Rating

Strong Buy

Jul 19, 2024

Lushang Freda Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.545B--
--2024/FY-- / 4.738B--
Mar 22, 20242023/FY4.579B / 4.544B--
Mar 31, 20232022/FY12.951B / 12.040B--
--2021/FY12.363B / 15.184B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.545B--
--2024/FY-- / 4.738B--
Mar 22, 20242023/FY4.579B / 4.544B--
Mar 31, 20232022/FY12.951B / 12.040B--
--2021/FY12.363B / 15.184B--

Unlock Free Earnings Estimates

Lushang Freda Pharmaceutical Earnings Reports

  • Lushang Freda Pharmaceutical Co., Ltd. Report for the first quarter of 2024

    Apr 29 12:00 ET

  • Lushang Freda Pharmaceutical Co., Ltd. 2023 Annual Report

    Mar 21 12:00 ET

  • Summary of the 2023 Annual Report of Lushang Freda Pharmaceutical Co., Ltd.

    Mar 21 12:00 ET

  • Lushang Freda Pharmaceutical Co., Ltd. 2023 Annual Results Forecast

    Jan 23 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 19, 2024

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      15.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg